George Clinical’s Scientific Leader, Jason Chandler, and members of the project operations and business development team will be attending the 61st ASH Meeting & Exposition in Orlando, Florida December 7–10.
The American Society of Hematology (ASH) annual meeting focuses on malignant and non-malignant hematology. The meeting will provide attendees the opportunity to review thousands of scientific abstracts highlighting updates and trends in hematology. In addition, network and exchange knowledge with leaders in the field and a global community of more than 25,000 hematology professionals from every subspecialty.
Are you looking for answers to questions about an upcoming project? Do you need assistance to ensure your project is a success? George Clinical provides expertise in the design and execution of oncology studies. Please contact us below to arrange a meeting to learn more about our experience in oncology as a leading global CRO.
Dr. Chandler focuses on blood cancers with a specific focus of cellular therapy in multiple myeloma and lymphoma. He heads up malignant hematology research at West Cancer Center in Memphis, TN. He spent five years as a member of the NCCN guidelines committee for multiple myeloma and is involved in multiple clinical trials ranging from Phase I to III in malignant hematology. Dr. Chandler has been involved with building a stem cell transplant/CAR-T program and is currently doing so again with a focus on out-patient administration.
Orange County Convention Center
9800 International Dr
Orlando, FL
USA
Meet with George Clinical! Contact us to schedule a time now.
